why choose us

First received: April 26, 2023

Clinical Trial: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Netherton Syndrome

Study Type: INTERVENTIONAL


Official Title: EvasayilTM : A Placebo-controlled Trial to Evaluate the Efficacy and Safety of Spesolimab in the Treatment of Patients With Netherton Syndrome

Brief Summary: This study is open to people with a skin disease called Netherton syndrome (NS).People can join the study if they are 12 years or older.The purpose of this study is to find out whether a medicine called spesolimab helps people with NS.Participants are divided into a spesolimab and a placebo group.Placebo injections look like spesolimab injections but do not contain any medicine.Every participant has a 2 in 3 chance of being in the spesolimab group.In the beginning, participants get the study medicine as an…

Read more